RecruitingNot ApplicableNCT06559605

Evaluation of Bone Gain Using Customized 3D Zirconia Barrier Versus Titanium Mesh

Clinical and Radiographic Evaluation of Bone Gain Using Customized 3D Printed Zirconia Barrier Versus Titanium Mesh in Combined Ridge Defects in The Aesthetic Zone: A Randomized Clinical Trial


Sponsor

Cairo University

Enrollment

26 participants

Start Date

May 22, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Evaluation of clinical and radiographical amount of bone gained using customized 3D printed zirconia barrier compared to titanium mesh in combined ridge defect at the esthetic zone.


Eligibility

Min Age: 20 YearsMax Age: 70 Years

Inclusion Criteria8

  • Age: 20-70 years.
  • Bone width less than 4mm
  • Vertical bone height less than 9mm
  • Periodontally sound neighboring teeth
  • Patients with sound vertical occlusal bite dimension
  • Good oral hygiene (full mouth plaque control record \[PCR\] < 25%,full mouth bleeding on probing (BOP) < 25% .
  • Patients demonstrating understanding and commitment to the post-operative care regime and the study follow up timeline.
  • Good general health (including participants with well-controlled systemic disease)

Exclusion Criteria5

  • Pathological lesions (abscess-cyst-acute infection) in the defect site
  • Systemic diseases that would interfere with bone metabolism
  • Uncontrolled diabetic patients
  • Ongoing treatment or a history of recent chemotherapy or radiotherapy
  • Poor oral hygiene after hygienic phase (Plaque control record over 30%) or Active periodontal disease

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREzirconia barrier

barrier membrane used for guided bone regeneration and augmentation of ridge defect

PROCEDUREtitanium mesh

barrier membrane used for guided bone regeneration


Locations(1)

Cairo university

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06559605


Related Trials